CYNTHIA CZUBA: Open Payments
NPI 1578861258 · ROLLING MEADOWS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 52 payments from 22 companies in 2025. Trend: 2023 $1,600 · 2024 $1,882 · 2025 $1,068
Food & beverage: $993Education: $75
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $338 |
| ABBVIE INC. | 5 | $100 |
| SOBI, INC | 1 | $75 |
| Octapharma USA, Inc. | 1 | $64 |
| Astellas Pharma US Inc | 2 | $53 |
| ARRAY BIOPHARMA INC | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Agios Pharmaceuticals, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Daiichi Sankyo Inc. | 1 | $28 |
Products named: SCEMBLIX, Fabhalta, Doptelet, OCTAGAM IMMUNE GLOBULIN (HUMAN), VENCLEXTA, KISQALI, PYRUKYND, JEMPERLI.
Industry payments across IL — which companies pay providers there.
